Tarceva (Erlotinib) for injection is used for the treatment of patients with non-small cell lung cancer

TARCEVA is a kinase inhibitor indicated for • Maintenance treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) whose disease has not progressed after four cycles of platinum-based first-line chemotherapy. • Treatment of locally advanced or metastatic non-small cell lung cancer after failure of at least one prior chemotherapy regimen. • First-line treatment of patients with locally advanced, unresectable or metastatic pancreatic cancer, in combination with gemcitabine.

Tarceva (Erlotinib) for injection suppliers in India. Indian Pharma Network (IPN) New Delhi, INDIA.

IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.

For procurement cost of Tarceva (Erlotinib) for injection brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the Tarceva (Erlotinib) for injection medicine cost price in India.

The order for Tarceva (Erlotinib) for injection will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Erlotinib, sold under the brand name Tarceva among others, is a medication used to treat non-small cell lung cancer (NSCLC) and pancreatic cancer. Specifically it is used for NSCLC with either an EGFR exon 19 deletion (del19) or exon 21 (L858R) substitution mutation which has spread to other parts of the body.

TARCEVA® (erlotinib) tablets, oral Initial U.S. Approval: 2004

Generic Name: Erlotinib

Tablets: 25 mg, 100 mg and 150 mg.

TARCEVA (erlotinib

with Indian Pharma Network

Indian Pharma Network, Delhi provides access to TARCEVA (erlotinib) on the Named Patient Import basis in India.

Tarceva (Erlotinib) for injection suppliers in India

IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand Tarceva (Erlotinib) for injection on prescription and Import License in Patient's Name only.

For overseas patients, Tarceva (Erlotinib) for injection can be made available in Send your enquiry to find Tarceva (Erlotinib) for injection in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.

News / Update for Tarceva (Erlotinib) for injection.

For Tarceva (Erlotinib) for injection Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details

Shilpa Medicare gets US FDA nod for its ANDA, Erlotinib tablets For More Details

FDA approves first-line Tecentriq plus chemotherapy for metastatic nonsquamous non-small cell lung cancer For More Details

IPN, New Delhi a trusted pharmaceutical exporter and wholesaler for Anti-Cancer Medicines in India.
Branch Office in India : New Delhi | Bengaluru | Kolkata | Lucknow | Jodhpur